🔎 Trials Near Me

Hem › Njurcancer (renalcelskarcinom) › Oklahoma

Kliniska studier för Njurcancer (renalcelskarcinom) i Oklahoma

8 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i Oklahoma.

Städer i Oklahoma

Officiell studietext (engelska)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Oklahoma City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT05433142

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • OU Stephenson Cancer Center, Oklahoma City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 8 juni 2026 · NCT06026410

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 mars 2026 · NCT07223541

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • Mercy Hospital Oklahoma City, Oklahoma City
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2025 · NCT04510597

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.